164 related articles for article (PubMed ID: 30459079)
21. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
[TBL] [Abstract][Full Text] [Related]
23. 3-Fluoro-3-deoxy-D-galactose: a new probe for studies on sugar cataract.
Secchi EF; Lizak MJ; Sato S; Kador PF
Curr Eye Res; 1999 Apr; 18(4):277-82. PubMed ID: 10372987
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of aldose reductase and xylose-induced lens opacity by puerariafuran from the roots of Pueraria lobata.
Kim NH; Kim YS; Lee YM; Jang DS; Kim JS
Biol Pharm Bull; 2010; 33(9):1605-9. PubMed ID: 20823582
[TBL] [Abstract][Full Text] [Related]
25. Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats.
Ji L; Cheng L; Yang Z
J Diabetes Res; 2017; 2017():7309816. PubMed ID: 29038789
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of Prunella vulgaris L. on aldose reductase and protein glycation.
Li HM; Kim JK; Jang JM; Kwon SO; Cui CB; Lim SS
J Biomed Biotechnol; 2012; 2012():928159. PubMed ID: 23091363
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
Bhadada SV; Vyas VK; Goyal RK
Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
[TBL] [Abstract][Full Text] [Related]
28. Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action.
Moghaddam MS; Kumar PA; Reddy GB; Ghole VS
J Ethnopharmacol; 2005 Feb; 97(2):397-403. PubMed ID: 15707781
[TBL] [Abstract][Full Text] [Related]
29. Thymol, a monoterpene, inhibits aldose reductase and high-glucose-induced cataract on isolated goat lens.
Kanchan DM; Kale SS; Somani GS; Kaikini AA; Sathaye S
J Pharm Bioallied Sci; 2016; 8(4):277-283. PubMed ID: 28216950
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
Sampath C; Sang S; Ahmedna M
Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794
[TBL] [Abstract][Full Text] [Related]
31. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory Activities of
Hwang SH; Kwon SH; Kim SB; Lim SS
Biomed Res Int; 2017; 2017():4273257. PubMed ID: 28326319
[No Abstract] [Full Text] [Related]
33. Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Lee YS; Lee S; Lee HS; Kim BK; Ohuchi K; Shin KH
Biol Pharm Bull; 2005 May; 28(5):916-8. PubMed ID: 15863906
[TBL] [Abstract][Full Text] [Related]
34. Esculetin, a Coumarin Derivative, Inhibits Aldose Reductase Activity in vitro and Cataractogenesis in Galactose-Fed Rats.
Kim CS; Kim J; Lee YM; Sohn E; Kim JS
Biomol Ther (Seoul); 2016 Mar; 24(2):178-83. PubMed ID: 26902086
[TBL] [Abstract][Full Text] [Related]
35. Isoflavonoids from the rhizomes of Belamcanda chinensis and their effects on aldose reductase and sorbitol accumulation in streptozotocin induced diabetic rat tissues.
Jung SH; Lee YS; Lee S; Lim SS; Kim YS; Shin KH
Arch Pharm Res; 2002 Jun; 25(3):306-12. PubMed ID: 12135102
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a novel aldose reductase inhibitor, FR74366, and its effects on diabetic cataract and neuropathy in the rat.
Ao S; Shingu Y; Kikuchi C; Takano Y; Nomura K; Fujiwara T; Ohkubo Y; Notsu Y; Yamaguchi I
Metabolism; 1991 Jan; 40(1):77-87. PubMed ID: 1898618
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic inhibition of aldose reductase.
Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
[TBL] [Abstract][Full Text] [Related]
38. Kinetic and molecular docking studies of loganin and 7-O-galloyl-D-sedoheptulose from Corni Fructus as therapeutic agents for diabetic complications through inhibition of aldose reductase.
Lee CM; Jung HA; Oh SH; Park CH; Tanaka T; Yokozawa T; Choi JS
Arch Pharm Res; 2015 Jun; 38(6):1090-8. PubMed ID: 25315636
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats.
Matsui T; Nakamura Y; Ishikawa H; Matsuura A; Kobayashi F
Jpn J Pharmacol; 1994 Feb; 64(2):115-24. PubMed ID: 8028228
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycation and aldose reductase activity using dietary flavonoids: A lens organ culture studies.
Patil KK; Gacche RN
Int J Biol Macromol; 2017 May; 98():730-738. PubMed ID: 28192136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
